title: The $2.6 billion pill--methodologic and policy considerations.
authors.affiliation: From Harvard Medical School and the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital - both in Boston.
authors.forename: Jerry
authors.initials: J
authors.lastname: Avorn
mesh_terms: D002201:Capital Expenditures / Q000706:statistics & numerical data; D017277:Drug Approval / Q000191:economics; D016527:Drug Costs; D055808:Drug Discovery / Q000191:economics*; D004345:Drug Industry / Q000191:economics*; D005380:Financing, Government; D009316:National Institutes of Health (U.S.); D012109:Research Support as Topic / Q000706:statistics & numerical data; D014481:United States